Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Although inadequate antimicrobial therapy has been demonstrated in multiple studies to increase the risk for death in bacterial infections, few data investigating the effect of antifungal therapy on outcome of serious fungal disease are available. We sought to assess the adequacy of empirical therapy and its effect on mortality in invasive Candida species infections. METHODS: Population-based surveillance of all patients with Candida spp. cultured from blood and/or cerebrospinal fluid was conducted. Adequacy of empirical therapy was assessed according to published guidelines. RESULTS: During a 5 year period, 207 patients had an invasive Candida spp. infection identified; in 199 cases (96%) adequate data were available for assessment of treatment and outcome at hospital discharge. One hundred and three (52%) cases were due to Candida albicans, 44 (22%) were due to Candida glabrata and the remainder were due to other species. Between the time of culture draw and reporting of a positive culture, only 64 (32%) patients were treated with empirical therapy; this was deemed adequate in 51 (26%). Patients who received adequate empirical therapy had a significant decrease in crude mortality [14/51 (27%) versus 68/148 (46%); risk ratio 0.60 (95% confidence interval 0.37-0.96); P = 0.02]. After adjusting for age and the need for intensive care unit admission in logistic regression analysis, the use of adequate empirical therapy was independently associated with a reduced risk for death [odds ratio 0.46 (95% confidence interval 0.22-1.00); P = 0.05]. CONCLUSIONS: Adequate empirical therapy is used in a minority of patients with invasive Candida spp. infections but is associated with improved survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although retrospective studies have suggested that empiric antifungal therapy might improve survival for select high-risk patients [28]”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [28]
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 2×
“Lastly, Kumar et al. 28 were able to demonstrate an increase in mortality with each hour of treatment delay in fungal septic shock (RR 1.06).”
BackgroundInfluentialInadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“Inappropriate initial antimicrobial therapies have been linked with increased patient fatality.(14) – 17,24,25 Subsequent corrected regimens following microbiological identification of the pathogen have not been associated with improved patient survival, thus highlighting the critical importance of correct initial ant…”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 2×
“Accordingly, many experts advocate early empirical antifungal therapies in patients deemed high risk.(2,20,21) However, no studies to date have specifically addressed the role of empirical antifungal therapies on patient outcome.”
BackgroundMethodNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 3×
“Garey et al. 18 further demonstrated in a multicentre retrospective study that for each successive day of delay in receipt of fluconazole treatment there was an increase in patient mortality.”
BackgroundHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Leroy, O., Gangneux, J.-P., Montravers, P., Mira, J.-P., Gouin, F., Sollet, J.-P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 535
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
“Parkins and colleagues investigated the relationship between the adequacy of initial empirical antifungal therapy and outcome of bloodstream and invasive Candida infections by reviewing 207 patients who had an invasive Candida infection over a 5-year period [43].”
BackgroundPfaller, M. A., & Diekema, D. J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00937-12 · Cited by 484
Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Pfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H.-U., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 394
Kett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314
Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238
Pfaller, M. A., Messer, S. A., Woosley, L. N., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00308-13 · Cited by 237
Hranjec, T., Rosenberger, L. H., Swenson, B., Metzger, R., Flohr, T. R., Politano, A. D., Riccio, L. M., Popovsky, K. A., & Sawyer, R. G. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70151-2 · Cited by 231
Montravers, P., Mira, J.-P., Gangneux, J.-P., Leroy, O., & Lortholary, O. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03360.x · Cited by 206
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 195
Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M. A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., & Antonelli, M. (2011) · Critical Care · doi:10.1186/cc10507 · Cited by 185
Pfaller, M. A., Castanheira, M., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.06.015 · Cited by 180
Suleyman, G., & Alangaden, G. J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.07.008 · Cited by 167
Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 164
Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults
Sandison, T., Ong, V., Lee, J., & Thye, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01627-16 · Cited by 161
Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
Anaissie, E., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159
T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis
Pfaller, M. A., Wolk, D. M., & Lowery, T. J. (2016) · Future Microbiology · doi:10.2217/fmb.15.111 · Cited by 157
Govender, N. P., Patel, J., Magobo, R. E., Naicker, S., Wadula, J., Whitelaw, A., Coovadia, Y., Kularatne, R., Govind, C., Lockhart, S. R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw091 · Cited by 147
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
Puig-Asensio, M., Pemán, J., Zaragoza, R., Garnacho-Montero, J., Martín-Mazuelos, E., Cuenca-Estrella, M., & Almirante, B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000221 · Cited by 147
Skull-base osteomyelitis: fungal vs. bacterial infection
Blyth, C. C., Gomes, L., Sorrell, T. C., Cruz, M. D., Sud, A., & Chen, S. C.-A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03231.x · Cited by 140
Treatment of invasive candidiasis in the elderly: a review
Dimοpoulos, G., Flevari, A., Θεοδωρακοπούλου, Μ., VELEGRAKI, & Armaganidis (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s39120 · Cited by 132
Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.03.002 · Cited by 130
Pfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00946-09 · Cited by 129
Risk Factors for Fluconazole-Resistant Candidemia
Garnacho-Montero, J., Díaz-Martín, A., García-Cabrera, E., Ruiz Pérez de Pipaón, M., Hernández-Caballero, C., Aznar-Martín, J., Cisneros, J. M., & Ortiz-Leyba, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00479-10 · Cited by 127
Vella, A., De Carolis, E., Vaccaro, L., Posteraro, P., Perlin, D. S., Kostrzewa, M., Posteraro, B., & Sanguinetti, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00903-13 · Cited by 124
Hanson, K. E., Pfeiffer, C. D., Lease, E. D., Balch, A. H., Zaas, A. K., Perfect, J. R., & Alexander, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042282 · Cited by 122
Fungal diagnosis: how do we do it and can we do better?
Perfect, J. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761134 · Cited by 120
Grim, S. A., Berger, K., Teng, C., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 118
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1339-6 · Cited by 117
Garnacho-Montero, J., Diaz-Martin, A., Garcia-Cabrera, E., Ruiz Perez de Pipaon, M., Hernandez-Caballero, C., & Lepe-Jimenez, J. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 112
Wang, H., Xiao, M., Chen, S. C.-A., Kong, F., Sun, Z.-Y., Liao, K., Lu, J., Shao, H.-F., Yan, Y., Fan, H., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01130-12 · Cited by 105
Management of invasive fungal infections: a role for polyenes
Chandrasekar, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq479 · Cited by 100
Aguado, J. M., Ruíz-Camps, I., Muñóz, P., Mensa, J., Almirante, B., Vázquez, L., Rovira, M., Martín‐Dávila, P., Moreno, A., Álvarez-Lerma, F., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.01.008 · Cited by 94
Leroy, G., Lambiotte, F., Thévenin, D., Lemaire, C., Parmentier, E., Devos, P., & Leroy, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-50 · Cited by 92
“Prompt initiation of appropriate antifungal therapy is essential for the control of invasive Candida infections and has been shown to reduce mortality [11-13].”
BackgroundInvasive candidiasis in intensive care units in China: a multicentre prospective observational study
Guo, F., Yang, Y., Kang, Y., Zang, B., Cui, W., Qin, B., Qin, Y., Fang, Q., Qin, T., Jiang, D., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt083 · Cited by 92
Chen, S. C., Sorrell, T. C., Chang, C. C., Paige, E. K., Bryant, P. A., & Slavin, M. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12597 · Cited by 88
Fraser, M., Brown, Z., Houldsworth, M., Borman, A. M., & Johnson, E. M. (2015) · Medical Mycology · doi:10.1093/mmy/myv085 · Cited by 86
Paiva, J.-A., Pereira, J. M., Tabah, A., Mikstacki, A., de Carvalho, F. B., Koulenti, D., Ruckly, S., Çakar, N., Misset, B., Dimopoulos, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1229-1 · Cited by 84
Invasive fungal infections in patients with cancer in the Intensive Care Unit
Sipsas, N. V., & Kontoyiannis, D. P. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.017 · Cited by 81
Holley, A., Dulhunty, J. M., Blot, S. I., Lipman, J., Lobo, S. M., Dancer, C., Rello, J., & Dimopoulos, G. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.035 · Cited by 81
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S.-C., da Luz Martins, M., Duse, A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.01.002 · Cited by 80
“Adequate antifungal therapy means that not only must the agent(s) be administered early in the course of infection, but also that the drugs must be active against the infecting organism and given in the correct dose (Collins et al., 2007; Garey et al., 2006, 2007; Morrell et al., 2005; Parkins et al., 2007; Wilson et…”
BackgroundMethodInfluentialThe value of amphotericin B in the treatment of invasive fungal infections
Klepser, M. E. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.08.005 · Cited by 77
Invasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
Kumar, A. (2009) · Critical Care Clinics · doi:10.1016/j.ccc.2009.08.004 · Cited by 76
B, V. H., Bruynseels, P., Bensaid, M., Boekhout, T., Baere, T. D., Surmont, I., & Mertens, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1383-y · Cited by 73
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Yang, Z.-T., Wu, L., Liu, X.-Y., Zhou, M., Li, J., Wu, J.-Y., Cai, Y., Mao, E.-Q., Chen, E.-Z., & Lortholary, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-241 · Cited by 71
Greenberg, R. G., Benjamin, D. K., Gantz, M. G., Cotten, C. M., Stoll, B. J., Walsh, M. C., Sánchez, P. J., Shankaran, S., Das, A., Higgins, R. D., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.053 · Cited by 70
Schreiber, J., Nierhaus, A., Braune, S. A., de Heer, G., & Kluge, S. (2013) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0227-1 · Cited by 69
Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia
Kim, S.-H., Yoon, Y. K., Kim, M. J., & Sohn, J. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt256 · Cited by 68
Current diagnostic approaches to invasive candidiasis in critical care settings
Pemán, J., & Zaragoza, R. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01732.x · Cited by 68
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
Bassetti, M., Vena, A., Giacobbe, D. R., Trucchi, C., Ansaldi, F., Antonelli, M. M., Adámková, V., Alicino, C., Almyroudi, M. P., Atchade, E., et al. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00585-6 · Cited by 66
Pfaller, M. A., Messer, S. A., Rhomberg, P. R., & Castanheira, M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.028 · Cited by 65
Optimizing antifungal choice and administration
Andes, D. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761135 · Cited by 63
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Sampaio, P., & Pais, C. (2014) · Current Clinical Microbiology Reports · doi:10.1007/s40588-014-0002-y · Cited by 62
Al-Dorzi, H. M., Sakkijha, H., Khan, R., Aldabbagh, T., Toledo, A., Ntinika, P., Al Johani, S. M., & Arabi, Y. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066618767835 · Cited by 61
Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02161-10 · Cited by 61
Mortality and risk factor analysis for Candida blood stream infection: A multicenter study
Kato, H., Yoshimura, Y., Suido, Y., Shimizu, H., Ide, K., Sugiyama, Y., Matsuno, K., & Nakajima, H. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.01.002 · Cited by 61
Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
G-Dayanandan, N., Paulsen, J. L., Viswanathan, K., Keshipeddy, S. K., Lombardo, M. N., Zhou, W., Lamb, K. M., Sochia, A. E., Alverson, J. B., Priestley, N. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401916j · Cited by 59
Chaubey, V. P., Pitout, J. D. D., Dalton, B., Ross, T., Church, D. L., Gregson, D. B., & Laupland, K. B. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-116 · Cited by 59
Self-citationBench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Pitarch, A., Nombela, C., & Gil, C. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025093146 · Cited by 56
Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis
Arendrup, M. C., Andersen, J. S., Holten, M., Krarup, K. B., Reiter, N., Schierbeck, J., & Helleberg, M. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz136 · Cited by 56
the study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI), Pemán, J., Zaragoza, R., Quindós, G., Alkorta, M., Cuétara, M. S., Camarena, J. J., Ramírez, P., Giménez, M. J., Martín‐Mazuelos, E., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-60 · Cited by 55
Diagnostic challenges and recent advances in the early management of invasive fungal infections
Chandrasekar, P. H. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01391.x · Cited by 55
Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey
Kutlu, M., Kutlu, S. S., Çavuş, S. A., Öztürk, Ş. B., Tasbakan, M. I., Özhak, B., Kaya, O., Kutsoylu, O. Ö. E., Akar, Ş. Ş., Turhan, Ö., et al. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04394-0 · Cited by 54
Tumbarello, M., Sanguinetti, M., Trecarichi, E. M., La Sorda, M., Rossi, M., de Carolis, E., de Gaetano Donati, K., Fadda, G., Cauda, R., & Posteraro, B. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn381 · Cited by 53
Recent Advances in Antifungal Prevention and Treatment
Groll, A. H., & Tragiannidis, A. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.03.003 · Cited by 51
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
Savage, R. D., Fowler, R. A., Rishu, A. H., Bagshaw, S. M., Cook, D., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154944 · Cited by 49
Is Candida really a threat in the ICU?
Blot, S. I., Dimopoulos, G., Rello, J., & Vogelaers, D. (2008) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32830f1dff · Cited by 49
Pemán, J., Cantón, E., Camarena, J. J., Alcoba-Flórez, J., Echeverría, J., Ortega, D. N., Alarcón, J. M., Fontanals, D., Sard, B. G., Moreno, B. B., et al. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.02.005 · Cited by 48
Comparison of albicans vs. non-albicans candidemia in French intensive care units
Leroy, O., Mira, J.-P., Montravers, P., Gangneux, J.-P., Lortholary, O., & the AmarCand Study Group (2010) · Critical Care · doi:10.1186/cc9033 · Cited by 47
Playford, E. G., Eggimann, P., & Calandra, T. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283177967 · Cited by 46
Zaragoza, R., Perman, J., Salavert, M., Viudes, Solé, A., Jarque, I., Cantón, R., Monte‐Boquet, E., & Romá, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3994 · Cited by 46
Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance
Hall, G. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5 · Cited by 43
Prophylaxis, empirical and preemptive treatment of invasive candidiasis
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e10e8 · Cited by 41
An investigation of antifungal stewardship programmes in England
Micallef, C., Ashiru-Oredope, D. A. I., Hansraj, S., Denning, D. W., Agrawal, S. G., Manuel, R. J., Schelenz, S., Guy, R. L., Müller‐Pebody, B., Patel, R., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000612 · Cited by 41
Walker, B. S., Powers‐Fletcher, M. V., Schmidt, R. L., & Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02971-15 · Cited by 40
Risk prediction for invasive candidiasis
Baronia, A. K., & Marak, K. R. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.142178 · Cited by 40
Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit
Viale, P. (2009) · Drugs · doi:10.2165/11315640-000000000-00000 · Cited by 40
Invasive mold infections: recent advances in management approaches
Chandrasekar, P. H. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902777434 · Cited by 39
Bruyère, R., Quenot, J., Prin, S., Dalle, F., Vigneron, C., Aho, S., León, C., & Charles, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-385 · Cited by 38
Imtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 37
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
Müderris, T., Kaya, S., Örmen, B., Gökmen, A. A., Akpınar, C. V., & Gül, S. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101008 · Cited by 37
Pharmacotherapy of yeast infections
Gómez‐López, A., Zaragoza, Ó., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2801 · Cited by 36
Metadata
- Authors
- Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Laupland, Kevin B.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-18
- Volume
- 60
- Issue
- 3
- Pages
- 613-618
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2137351193
- Semantic Scholar
- 80b38a8f43278681a310601609c65ad32cfe938e
- Cited by
- 229
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 14 · 2016: 15 · 2015: 10 · 2014: 17 · 2013: 20 · 2012: 17
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, empirical antifungal therapy, treatment adequacy, mortality, Candida albicans, Candida glabrata, fungemia, cerebrospinal fluid culture, guideline adherence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alberta, Analysis of Variance, Antifungal Agents, Calibration, Candida, Candidiasis, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Terminology as Topic, Risk Factors, Cohort Studies, Logistic Models, Odds Ratio, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.